Diagnostics
You are what you eat, and your defense system notices that.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Roche’s investment is aimed at supporting the development of Freenome’s colorectal cancer detection technology.
Sigyn is not only trying to treat the inflammatory mediators that fuel sepsis; it wants to prevent the life-threatening event from occurring altogether.
SomaLogic and Illumina have come together to propel innovation in Proteomics. This partnership represents the rapidly growing high throughput sector of the proteomics market
The year kicked off with a bang as multiple companies raced to a public listing.
This liquid biopsy uses a panel of peptide biosensors to analyze protein activity from a blood sample and provide actionable readouts of the disease state.
This year’s top 30 large and small companies operate in some of the Life Sciences’ hottest spaces – precision medicine, vaccines, gene editing, genomics and oncology.
Research into Alzheimer’s disease is shifting from amyloid plaque and tau protein to neuroinflammation, white matter changes and insulin resistance.
The life sciences industry might just be filling a bit richer this week as two major venture capital firms announced the closing of new funds.
PRESS RELEASES
